Rockefeller Capital Management L.P. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,687,064
+31.8%
70,342
+24.4%
0.01%
+25.0%
Q2 2023$2,039,037
+146277.4%
56,530
+55.0%
0.01%
+33.3%
Q1 2023$1,393
-25.5%
36,482
+10.9%
0.01%
-33.3%
Q4 2022$1,871
-99.5%
32,883
+228.4%
0.01%
+350.0%
Q3 2022$395,000
-15.4%
10,014
-5.8%
0.00%0.0%
Q2 2022$467,000
+41.1%
10,627
+27.9%
0.00%0.0%
Q1 2022$331,000
-3.5%
8,307
-2.8%
0.00%0.0%
Q4 2021$343,000
+1.5%
8,549
+2.8%
0.00%0.0%
Q3 2021$338,000
+1200.0%
8,313
+1350.8%
0.00%
Q2 2021$26,000
+18.2%
573
+7.5%
0.00%
Q1 2021$22,000
+4.8%
533
+6.6%
0.00%
Q4 2020$21,000
+61.5%
5000.0%0.00%
Q3 2020$13,000
-92.0%
500
-91.8%
0.00%
-100.0%
Q2 2020$163,000
+24.4%
6,088
-16.7%
0.00%0.0%
Q1 2020$131,000
+1355.6%
7,305
+1361.0%
0.00%
Q4 2019$9,0005000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders